PRENW — Prenetics Global Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1876431 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 35,954,000 | 23,283,000 | -9,706,000 | -23,104,000 | 175,302,000 | 56,017,000 | 54,280,000 |
| Dec 2025 | 36,558,000 | 21,588,000 | -13,136,000 | -7,501,000 | 206,073,000 | 32,131,000 | 49,707,000 |
| Sep 2025 | 23,555,000 | 14,024,000 | -6,559,000 | -7,408,000 | 196,507,000 | 13,264,000 | 35,305,000 |
| Jun 2025 | 17,680,000 | 7,289,000 | -9,869,000 | -12,410,000 | 199,106,000 | 17,249,000 | 48,214,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,382,000
Investing CF
$30,191,000
Financing CF
$-14,619,000
CapEx
—
Dividends Paid
$0
Buybacks
$-13,117,000
EPS Diluted TTM
—
As of
2026-06-12
Balance + Analyst (yfinance extras)
Retained Earnings
$-554,781,000
Inventory
$14,198,000
Receivables
$11,875,000
ST Investments
$50,018,000
EBIT TTM
$-36,932,000
Pretax Income TTM
$-54,699,000
Interest Exp TTM
$234,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$154,592,992
EBITDA
$-54,805,000
Free Cash Flow
$-36,112,376
Enterprise Value
—
Total Cash
$128,557,000
Total Debt
$682,000
Shares Out
—
Trailing EPS
$-11.04
Book Value
$5.39
ROE
-47.0%
ROA
-18.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 92,390,000 | -38,129,000 | -37,709,000 | 206,073,000 | 49,707,000 | — | -21,826,000 |
| Dec 2024 | 15,936,000 | -38,277,000 | -46,304,000 | 213,575,000 | 42,229,000 | — | -28,874,000 |
| Dec 2023 | 6,155,000 | -42,469,000 | -62,724,000 | 254,171,000 | 44,013,000 | — | -13,765,000 |
| Dec 2022 | 13,164,000 | -65,917,000 | -190,454,000 | 312,131,231 | 68,668,371 | — | 14,515,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.11T | $1246.93 | — |
| JNJ | JOHNSON & JOHNSON | $658.00B | $273.04 | — |
| ABBV | AbbVie Inc. | $467.44B | $264.52 | — |
| MRK | Merck & Co., Inc. | $371.70B | $150.66 | — |
| NVSEF | NOVARTIS AG | $310.96B | $163.60 | — |
News headlines (Yahoo Finance, 1h cache)
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
2026-07-14 17:35 · Yahoo
Prenetics Global Ltd (PRE) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...
2026-08-21 01:02 · Yahoo
Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-08-20 13:00 · Yahoo
Prenetics Global Limited Q2 2026 Earnings Call Summary
2026-08-19 12:30 · Yahoo
Prenetics Global Q2 Earnings Call Highlights
2026-08-18 15:02 · Yahoo
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expect
2026-08-18 14:07 · Yahoo
PRE Posts Blockbuster Results
2026-08-18 11:30 · Yahoo
Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director
2026-08-17 12:30 · Yahoo
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
2026-08-07 12:30 · Yahoo
PRE Continues to Exceed Expectations and Receive Preferential Financing
2026-07-15 12:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.